Product Images Gabapentin
View Photos of Packaging, Labels & Appearance
Product Label Images
The following 7 images provide visual information about the product associated with Gabapentin NDC 68788-7847 by Preferred Pharmaceuticals Inc., such as packaging, labeling, and the appearance of the drug itself. This resource could be helpful for medical professionals, pharmacists, and patients seeking to verify medication information and ensure they have the correct product.
Gabapentin Tablets 600mg Tablets
Gabapentin Tablets 600mg are used for patients as prescribed by their doctor. These tablets are generic for Neurontin and each film-coated tablet contains 600mg of Gabapentin. It is important to note that federal law prohibits the transfer of this drug to any person other than the patient for whom it was prescribed. Instructions are also available in Spanish. Lot and batch numbers are provided on the packaging.*
Figure 1 - image 01
This is a chart showing the mean pain scores for two different treatment groups (fixed dose and dose titration) compared to a placebo group. The chart also includes information on the medication Gabapentin at a dosage of 3600 mg/day. The pain scores are measured at baseline and over a period of multiple weeks.*
Figure 2 - image 02
This is a graph showing the mean pain score for different treatments (placebo, Gabapentin 1800 mg/day, and Gabapentin 2400 mg/day) over a 4-week fixed dose period. The x-axis represents the weeks and the y-axis represents the pain score.*
Figure 3 - image 03
image-04 - image 04
Gabapentin Structural Formula - image 05
Figure 4. Responder Rate in Patients Receiving gabapentin Expressed as a Difference from Placebo by Dose and Study: Adjunctive Therapy Studies in Patients ≥12 Years of Age with Partial Seizures - image 09
* The product label images have been analyzed using a combination of traditional computing and machine learning techniques. It should be noted that the descriptions provided may not be entirely accurate as they are experimental in nature. Use the information in this page at your own discretion and risk.